Page last updated: 2024-12-05

pentafluoroethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Pentafluoroethane, also known as R-125, is a colorless, odorless, and non-flammable gas. It is a synthetic compound used as a refrigerant, blowing agent, and propellant. Pentafluoroethane is produced through the fluorination of ethane or by the reaction of tetrafluoroethylene with hydrogen fluoride. Its primary use is as a refrigerant in refrigeration and air conditioning systems, due to its high refrigerating capacity and low global warming potential compared to some other refrigerants. It is also used as a blowing agent in the production of foams, and as a propellant in aerosols. Studies on pentafluoroethane often focus on its environmental impact, including its atmospheric lifetime and contribution to global warming. Researchers investigate its potential use in sustainable refrigerants and the development of alternative technologies to reduce its environmental footprint.'

Cross-References

ID SourceID
PubMed CID9633
SCHEMBL ID5439
MeSH IDM0209827

Synonyms (42)

Synonym
ethane, pentafluoro-
c2f5h
khladon 125
un3220
hcfc 125
hfc 125
fc 125
einecs 206-557-8
fron 125
r 125
hsdb 6755
ccris 7630
1,1,2,2,2-pentafluoroethane
hfc-125
inchi=1/c2hf5/c3-1(4)2(5,6)7/h1
1,1,1,2,2-pentafluoroethane
354-33-6
pentafluoroethane
FT-0658782
AKOS006230211
ecolo ace 125
hfa 125
ethane, 1,1,1,2,2-pentafluoro-
pentafluoroethane or refrigerant gas r 125 [un3220] [nonflammable gas]
ec 206-557-8
pentafluoroethane or refrigerant gas r 125
hfo 125
unii-6tq8593lrq
6tq8593lrq ,
freon 125
SCHEMBL5439
chf2cf3
pentafluoroethane [hsdb]
fc-125
r-125
genetron hfc 125
DTXSID1024251
mfcd00042101
pentafluoroethane 99%
Q419065
AMY37170
ethyl, 1,1,2,2,2-pentafluoro-

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The acute toxic endpoint of concern for these agents is cardiac sensitization."( Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling.
Brock, WJ; Cisneros, M; Jepson, GW; Rubenstein, R; Vinegar, A, 2000
)
0.31

Pharmacokinetics

ExcerptReferenceRelevance
" Linkage was made using a physiologically based pharmacokinetic (PBPK) model."( Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling.
Brock, WJ; Cisneros, M; Jepson, GW; Rubenstein, R; Vinegar, A, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's5 (29.41)29.6817
2010's9 (52.94)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.69 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index73.62 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]